Wednesday 15 April 2026

One To Watch

Allecra Therapeutics


Want to Update your Company's Profile?


Latest Allecra Therapeutics News

The week in pharma: action, reaction and insight – week to March 1, 2024
3 March 2024
Allecra Therapeutics gets US FDA approval for Exblifep
27 February 2024
Cefepime/enmetazobactam meets criteria for superiority in Phase III trial
5 October 2022
Advanz Pharma gets rights to Allecra antibiotic
13 January 2022
More Allecra Therapeutics news >


Today's issue

CrossBridge Bio latest ADC firm to be snapped up in Lilly deal
Biotechnology
CrossBridge Bio latest ADC firm to be snapped up in Lilly deal
14 April 2026
Biotechnology
FDA draft guidance on genome editing safety standards
14 April 2026
Pharmaceutical
MHRA approves new high dose regimen of Spinraza
14 April 2026
Biotechnology
Positive Phase III results for Jaypirca in new CLL group
14 April 2026
Pharmaceutical
Travere’s Filspari wins landmark US approval
14 April 2026
Biotechnology
Adcendo completes $75 million Series C financing
14 April 2026
Biotechnology
SynOx Therapeutics heading for FDA filing for emactuzumab in TGCT
14 April 2026




Copyright © The Pharma Letter 2026

 |  Headless Content Management with Blaze